NUCOR ($NUE) posted quarterly earnings results for Q1 2026 on Monday, April 27th. The company reported earnings of $3.23 per share, beating estimates of $2.84 by $0.39. The company also reported revenue of $9,496,000,000, beating estimates of $8,969,936,138 by $526,063,862.
Stock price change since market close: +4.42%
You can see Quiver Quantitative's $NUE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NUCOR Insider Trading Activity
NUCOR insiders have traded $NUE stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $NUE stock by insiders over the last 6 months:
- ALLEN C BEHR (Executive Vice President) has made 0 purchases and 4 sales selling 30,060 shares for an estimated $5,091,928.
- LEON J TOPALIAN (Chair and CEO) has made 0 purchases and 3 sales selling 16,500 shares for an estimated $2,655,037.
- KENNETH REX QUERY (Executive Vice President) sold 7,452 shares for an estimated $1,460,736
- JOHN J HOLLATZ (Executive Vice President) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $1,049,160.
- DANIEL R. NEEDHAM (Executive Vice President) sold 3,881 shares for an estimated $690,818
- THOMAS J. BATTERBEE (Executive Vice President) sold 2,000 shares for an estimated $330,550
- STEPHEN D LAXTON (CFO and EVP) has made 0 purchases and 9 sales selling 2,003 shares for an estimated $303,599.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
NUCOR Hedge Fund Activity
We have seen 610 institutional investors add shares of NUCOR stock to their portfolio, and 522 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,338,215 shares (-74.9%) from their portfolio in Q4 2025, for an estimated $544,496,248
- JPMORGAN CHASE & CO removed 657,819 shares (-44.9%) from their portfolio in Q4 2025, for an estimated $107,296,857
- SG AMERICAS SECURITIES, LLC added 599,667 shares (+701.6%) to their portfolio in Q1 2026, for an estimated $101,403,689
- CITADEL ADVISORS LLC added 566,486 shares (+186.0%) to their portfolio in Q4 2025, for an estimated $92,399,531
- HOLOCENE ADVISORS, LP removed 548,911 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $89,532,873
- PENTWATER CAPITAL MANAGEMENT LP removed 400,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $65,244,000
- BANK OF NEW YORK MELLON CORP added 383,952 shares (+27.5%) to their portfolio in Q4 2025, for an estimated $62,626,410
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
NUCOR Analyst Ratings
Wall Street analysts have issued reports on $NUE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 12/18/2025
- Jefferies issued a "Buy" rating on 12/10/2025
- Citigroup issued a "Buy" rating on 10/30/2025
To track analyst ratings and price targets for NUCOR, check out Quiver Quantitative's $NUE forecast page.
NUCOR Price Targets
Multiple analysts have issued price targets for $NUE recently. We have seen 7 analysts offer price targets for $NUE in the last 6 months, with a median target of $190.0.
Here are some recent targets:
- Timna Tanners from Wells Fargo set a target price of $213.0 on 04/16/2026
- Bill Peterson from JP Morgan set a target price of $212.0 on 04/14/2026
- Andrew Jones from UBS set a target price of $190.0 on 03/26/2026
- Carlos De Alba from Morgan Stanley set a target price of $180.0 on 01/09/2026
- Christopher LeFemina from Jefferies set a target price of $190.0 on 12/10/2025
- Alexander Hacking from Citigroup set a target price of $180.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.